We found EGFR/MET were mainly expressed in HCC cells of carcinoma tissue, which differed from some RTKs for clinical targets expressed mainly in peritumor tissue such as the PDGFR family (Fig. 2F). Here, MET is linked to hepatocellular carcinoma.